Genpharmasec Statistics

Total Valuation

Genpharmasec has a market cap or net worth of INR 1.09 billion. The enterprise value is 1.11 billion.

Market Cap	1.09B
Enterprise Value	1.11B

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

Genpharmasec has 533.72 million shares outstanding.

Current Share Class	533.72M
Shares Outstanding	533.72M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+17.03%
Owned by Insiders (%)	49.73%
Owned by Institutions (%)	5.30%
Float	252.59M

Valuation Ratios

The trailing PE ratio is 77.94.

PE Ratio	77.94
Forward PE	n/a
PS Ratio	3.66
PB Ratio	1.67
P/TBV Ratio	1.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	69.62
EV / Sales	3.70
EV / EBITDA	194.97
EV / EBIT	209.71
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.07
Debt / EBITDA	8.63
Debt / FCF	n/a
Interest Coverage	1.09

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	0.74%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	29.91M
Profits Per Employee	1.59M
Employee Count	10
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.00% in the last 52 weeks. The beta is -0.81, so Genpharmasec's price volatility has been lower than the market average.

Beta (5Y)	-0.81
52-Week Price Change	+3.00%
50-Day Moving Average	2.06
200-Day Moving Average	2.70
Relative Strength Index (RSI)	51.37
Average Volume (20 Days)	316,037

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genpharmasec had revenue of INR 299.11 million and earned 15.89 million in profits. Earnings per share was 0.03.

Revenue	299.11M
Gross Profit	61.41M
Operating Income	5.27M
Pretax Income	24.17M
Net Income	15.89M
EBITDA	5.42M
EBIT	5.27M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 38.20 million in cash and 48.94 million in debt, giving a net cash position of -10.74 million or -0.02 per share.

Cash & Cash Equivalents	38.20M
Total Debt	48.94M
Net Cash	-10.74M
Net Cash Per Share	-0.02
Equity (Book Value)	655.11M
Book Value Per Share	1.27
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 20.53%, with operating and profit margins of 1.76% and 5.31%.

Gross Margin	20.53%
Operating Margin	1.76%
Pretax Margin	8.08%
Profit Margin	5.31%
EBITDA Margin	1.81%
EBIT Margin	1.76%
FCF Margin	n/a

Dividends & Yields

Genpharmasec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.45%
FCF Yield	n/a

Stock Splits

The last stock split was on April 11, 2019. It was a forward split with a ratio of 10.

Last Split Date	Apr 11, 2019
Split Type	Forward
Split Ratio	10

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a